The Journal of Experimental Medicine
Randox clinical diagnostic solutions
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 30 July 2001. doi:10.1084/jem.194.3.247
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruiz-Vela, A.
Right arrow Articles by Martínez-A, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz-Vela, A.
Right arrow Articles by Martínez-A, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/8/247/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 3, August 6, 2001 247-254


Original Article

Transplanted Long-Term Cultured Pre-BI Cells Expressing Calpastatin Are Resistant to B Cell Receptor–induced Apoptosis

Antonio Ruiz-Velaa, Fernando Serranoa, Manuel A. Gonzáleza, José Luis Abada, Antonio Bernada, Masatoshi Makib, and Carlos Martínez-Aa
a Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
b Department of Applied Molecular Biosciences, Nagoya University, Nagoya 464-8601, Japan

Correspondence to: Antonio Ruiz-Vela, Dept. Immunology and Oncology, Centro Nacional de Biotecnología CSIC, Campus de Cantoblanco UAM, E-28049 Madrid, Spain. Tel:34-91-585-4537 Fax:34-91-372-0493 E-mail:aruiz{at}cnb.uam.es.

Long-term cultured pre-B cells are able to differentiate into immunoglobulin (Ig)M-positive B cells (IgM+ cells) when transplanted into severe combined immunodeficient (SCID) mice. Based on previous studies, here we report the development of a reconstitution assay in nonobese diabetic/SCID (NOD/SCID) mice using pre-B cells, which allows us to study the role of calpains (calcium-activated endopeptidases) during B cell development as well as in B cell clonal deletion. Using this model, we show that calpastatin (the natural inhibitor of calpains) inhibits B cell receptor–induced apoptosis in IgM+ cells derived from transplanted mice. We thus hypothesize an important function for calpain in sculpting the B cell repertoire.

Key Words: pre-B cells, calpastatin, calpain, BCR, transplant


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS